Last reviewed · How we verify

Yunnan Baiyao — Competitive Intelligence Brief

Yunnan Baiyao (Yunnan Baiyao) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese medicine / Herbal preparation. Area: Hematology / Hemostasis.

marketed Traditional Chinese medicine / Herbal preparation Hematology / Hemostasis Small molecule Live · refreshed every 30 min

Target snapshot

Yunnan Baiyao (Yunnan Baiyao) — Peking University Third Hospital. Yunnan Baiyao is a traditional Chinese medicine formulation that promotes hemostasis and reduces bleeding through multiple herbal components.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Yunnan Baiyao TARGET Yunnan Baiyao Peking University Third Hospital marketed Traditional Chinese medicine / Herbal preparation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese medicine / Herbal preparation class)

  1. Peking University Third Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Yunnan Baiyao — Competitive Intelligence Brief. https://druglandscape.com/ci/yunnan-baiyao. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: